$662 Million is the total value of First Light Asset Management, LLC's 71 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 24.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $61,852,000 | +43.1% | 3,719,291 | +18.4% | 9.35% | +55.8% |
| MODN | Sell | MODEL N INC | $54,688,000 | +28.7% | 1,970,044 | -9.6% | 8.27% | +40.2% |
| OMCL | Buy | OMNICELL INC | $32,936,000 | +15.5% | 455,737 | +37.5% | 4.98% | +25.8% |
| KRMD | Buy | REPRO MED SYSTEMS INC | $28,361,000 | +43.0% | 7,180,017 | +4.3% | 4.29% | +55.7% |
| MYOK | Sell | MYOKARDIA INC | $27,845,000 | +3.2% | 533,944 | -0.8% | 4.21% | +12.4% |
| ATRC | Sell | ATRICURE INC | $27,576,000 | -16.9% | 1,105,709 | -0.5% | 4.17% | -9.5% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $26,099,000 | +42.3% | 1,682,745 | +57.6% | 3.94% | +54.9% |
| NEO | Sell | NEOGENOMICS INC | $25,234,000 | -13.2% | 1,319,746 | -0.4% | 3.82% | -5.5% |
| INSM | New | INSMED INC | $22,839,000 | – | 1,294,743 | +100.0% | 3.45% | – |
| SPNE | Buy | SEASPINE HOLDINGS CORP | $22,620,000 | -5.2% | 1,852,556 | +2.9% | 3.42% | +3.2% |
| XENT | Buy | INTERSECT ENT INC | $20,686,000 | +35.9% | 1,216,122 | +81.8% | 3.13% | +47.9% |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $20,493,000 | – | 764,096 | +100.0% | 3.10% | – |
| HRTX | Sell | HERON THERAPEUTICS INC | $20,186,000 | -1.2% | 1,091,110 | -0.7% | 3.05% | +7.6% |
| IONS | Sell | IONIS PHARMACEUTICALS INC | $19,450,000 | -7.5% | 324,649 | -0.8% | 2.94% | +0.7% |
| IMMU | Buy | IMMUNOMEDICS INC | $16,582,000 | -2.3% | 1,250,536 | +2.2% | 2.51% | +6.4% |
| CDXS | Sell | CODEXIS INC | $16,437,000 | -26.0% | 1,198,452 | -0.6% | 2.48% | -19.4% |
| AMRN | New | AMARIN CORPORATION | $13,930,000 | – | 918,846 | +100.0% | 2.11% | – |
| SIBN | Sell | SI-BONE INC | $11,415,000 | -13.8% | 645,982 | -0.8% | 1.73% | -6.1% |
| XNCR | Sell | XENCOR INC | $11,315,000 | -44.6% | 335,444 | -32.8% | 1.71% | -39.7% |
| ELGXQ | Buy | ENDOLOGIX INC | $11,292,000 | -36.7% | 2,844,317 | +15.5% | 1.71% | -31.0% |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $10,771,000 | -12.9% | 332,442 | +34.1% | 1.63% | -5.2% |
| TRHC | New | TABULA RASA HEALTHCARE INC | $10,732,000 | – | 195,347 | +100.0% | 1.62% | – |
| VCYT | Sell | VERACYTE INC | $9,862,000 | -41.3% | 410,925 | -30.2% | 1.49% | -36.1% |
| VAPO | Buy | VAPOTHERM INC | $9,695,000 | -15.2% | 1,023,734 | +106.0% | 1.47% | -7.6% |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $8,735,000 | +233.3% | 190,838 | +326.9% | 1.32% | +262.6% |
| TNDM | Sell | TANDEM DIABETES CARE INC | $8,041,000 | -8.9% | 136,328 | -0.4% | 1.22% | -0.8% |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL INC | $7,686,000 | -32.8% | 179,659 | -0.2% | 1.16% | -26.8% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $6,979,000 | +16.3% | 103,552 | +47.8% | 1.06% | +26.7% |
| TEVA | Sell | TEVA PHARMACEUTICAL IND | $6,668,000 | -25.7% | 969,230 | -0.3% | 1.01% | -19.1% |
| LHCG | Sell | LHC GROUP INC | $6,073,000 | -6.0% | 53,479 | -1.1% | 0.92% | +2.2% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $5,867,000 | -21.8% | 115,700 | -30.0% | 0.89% | -14.8% |
| TECH | Sell | BIO TECHNE CORP | $5,523,000 | -7.0% | 28,226 | -0.9% | 0.84% | +1.2% |
| CSII | Sell | CARDIOVASCULAR SYSTEMS INC | $5,030,000 | -38.0% | 105,856 | -44.0% | 0.76% | -32.6% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $4,935,000 | -56.2% | 49,578 | -49.7% | 0.75% | -52.3% |
| TRUP | Sell | TRUPANION INC | $4,901,000 | -30.4% | 192,797 | -1.0% | 0.74% | -24.2% |
| TAK | Sell | TAKEDA PHARMACEUTICAL CO | $4,871,000 | -33.6% | 283,200 | -31.7% | 0.74% | -27.8% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $4,509,000 | -8.5% | 26,615 | -1.0% | 0.68% | -0.3% |
| SLP | Sell | SIMULATIONS PLUS INC | $4,338,000 | -40.1% | 125,012 | -50.7% | 0.66% | -34.7% |
| KIDS | Sell | ORTHOPEDIATRICS CORP | $4,302,000 | -10.5% | 122,016 | -1.0% | 0.65% | -2.5% |
| MYL | Sell | MYLAN N V | $3,724,000 | -73.7% | 188,290 | -74.7% | 0.56% | -71.4% |
| QDEL | Sell | QUIDEL CORP | $3,336,000 | +2.4% | 54,369 | -1.0% | 0.50% | +11.3% |
| TLGT | Sell | TELIGENT INC | $3,053,000 | +50.2% | 3,213,936 | -0.4% | 0.46% | +63.8% |
| ADRO | Sell | ADURO BIOTECH INC | $2,647,000 | -52.5% | 2,497,022 | -31.0% | 0.40% | -48.3% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $2,615,000 | -25.8% | 26,698 | -0.8% | 0.40% | -19.4% |
| FIXX | New | HOMOLOGY MEDICINES INC. | $2,578,000 | – | 142,449 | +100.0% | 0.39% | – |
| ALKS | Sell | ALKERMES PLC | $2,402,000 | -53.3% | 123,107 | -46.0% | 0.36% | -49.2% |
| IBB | ISHARES NASDAQ BIOTECHNOLOGY ETFetf | $2,114,000 | -8.8% | 21,248 | 0.0% | 0.32% | -0.6% | |
| EPZM | Sell | EPIZYME INC | $2,043,000 | -18.6% | 198,059 | -1.0% | 0.31% | -11.5% |
| PSCH | INVESCO SMALLCAP HEALTH CARE ETFetf | $1,961,000 | -3.8% | 17,285 | 0.0% | 0.30% | +4.6% | |
| IHI | ISHARES US MEDICAL DEVICES ETFetf | $1,874,000 | +2.7% | 7,580 | 0.0% | 0.28% | +11.9% | |
| NVTRQ | Sell | NUVECTRA CORP | $1,815,000 | -59.5% | 1,334,512 | -0.3% | 0.27% | -55.9% |
| BLUE | Sell | BLUEBIRD BIO INC | $1,711,000 | -28.6% | 18,639 | -1.1% | 0.26% | -22.2% |
| LMAT | Sell | LEMAITRE VASCULAR INC | $1,675,000 | +20.9% | 48,992 | -1.1% | 0.25% | +31.8% |
| XLV | HEALTH CARE SELECT SECTOR SPDR ETFetf | $1,644,000 | -2.7% | 18,241 | 0.0% | 0.25% | +6.0% | |
| TMDX | TRANSMEDICS GROUP INC | $641,000 | -18.1% | 27,000 | 0.0% | 0.10% | -11.0% | |
| AGN | ALLERGAN PLC SHS | $363,000 | +0.6% | 2,157 | 0.0% | 0.06% | +10.0% | |
| MRK | MERCK & CO INC | $358,000 | +0.6% | 4,247 | 0.0% | 0.05% | +10.2% | |
| HCAT | New | HEALTH CATALYST INC | $351,000 | – | 11,100 | +100.0% | 0.05% | – |
| SNY | SANOFI-SYNTHELABO | $308,000 | +6.9% | 6,650 | 0.0% | 0.05% | +17.5% | |
| ABBV | ABBVIE | $312,000 | +4.3% | 4,114 | 0.0% | 0.05% | +11.9% | |
| PFE | PFIZER INC | $304,000 | -17.2% | 8,469 | 0.0% | 0.05% | -9.8% | |
| NVS | NOVARTIS AG-SPONSORED ADR | $307,000 | -5.0% | 3,535 | 0.0% | 0.05% | +2.2% | |
| BAX | BAXTER INTERNATIONAL INC | $285,000 | +6.7% | 3,258 | 0.0% | 0.04% | +16.2% | |
| JNJ | JOHNSON AND JOHNSON | $280,000 | -7.0% | 2,161 | 0.0% | 0.04% | 0.0% | |
| TXG | New | 10X GENOMICS INC CLASS A | $252,000 | – | 5,000 | +100.0% | 0.04% | – |
| STE | STERIS CORP | $238,000 | -3.3% | 1,649 | 0.0% | 0.04% | +5.9% | |
| HRC | HILL-ROM HOLDINGS INC | $223,000 | +0.5% | 2,121 | 0.0% | 0.03% | +9.7% | |
| SNN | New | SMITH & NEPHEW PLC SPONSORED ADR | $215,000 | – | 4,472 | +100.0% | 0.03% | – |
| AMGN | AMGEN INC | $211,000 | +5.0% | 1,092 | 0.0% | 0.03% | +14.3% | |
| GRFS | GRIFOLS SA SPONSORED ADR CLASS B | $204,000 | -5.1% | 10,166 | 0.0% | 0.03% | +3.3% | |
| DYNT | Buy | DYNATRONICS CORP | $122,000 | -37.1% | 121,267 | +3.1% | 0.02% | -33.3% |
| DHR | Exit | DANAHER CORP | $0 | – | -1,400 | -100.0% | -0.03% | – |
| ANTM | Exit | ANTHEM INC COM | $0 | – | -795 | -100.0% | -0.03% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -797 | -100.0% | -0.03% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC. | $0 | – | -3,000 | -100.0% | -0.06% | – |
| HBIO | Exit | HARVARD BIOSCIENCE INC | $0 | – | -588,148 | -100.0% | -0.16% | – |
| CLLS | Exit | CELLECTIS SA | $0 | – | -75,843 | -100.0% | -0.16% | – |
| HSTM | Exit | HEALTHSTREAM INC | $0 | – | -90,924 | -100.0% | -0.33% | – |
| AERI | Exit | AERIE PHARMACEUTICALS INC | $0 | – | -478,174 | -100.0% | -1.96% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -713,769 | -100.0% | -3.53% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -1,212,545 | -100.0% | -7.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.